NEWSLETTERS - The Huntington's Disease News
By AICH - Roma Onlus
View this email in your browser
Newsletters 14 Mar.  2016
Huntington's disease news
Mar 16, 2016
Human stem cells target Huntington’s disease

In a promising finding for research into Huntington’s disease (HD) — the devastating inherited neurodegenerative disorder — a team of UC Davis investigators has identified for the first time a way to use human mesenchymal stem cells (MSCs) to deliver the key brain protein growth factor that is dramatically diminished by Huntington’s disease. The discovery could be the precursor to developing a successful therapy to treat those who suffer from the disease.
Mar 22, 2016
uniQure Announces Preclinical Proof of Concept for Gene Therapy Approach in Huntington’s Disease

 uniQure N.V. a leader in human gene therapy, today announced the publication of preclinical data supporting its proprietary Huntington’s disease gene therapy program, AMT-130. Findings published in the current issue of the peer-reviewed journal Molecular Therapy-Nucleic Acids( provide preclinical proof of concept for uniQure’s AMT-130 program and demonstrate the potential of a one-time administration of AAV5-delivered gene therapy into the central nervous system
Copyright © 2016 aichroma, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp